Interventional cardiology & peripheral vascular devices market is driven by increasing count of aging population and rising demand for angioplasty procedures which are minimally invasive. Furthermore, technological enhancements in interventional cardiology & peripheral vascular devices is expected to boost the market growth. The application of preliminary conventional first-level medication and rising cases of product recall is expected to hinder the market growth. Demand of stents having bioabsorbable properties across emerging markets is anticipated to offer abundant growth opportunities. Irregularity in reimbursements along with entry barriers for new players are the key market challenges. Research Beam Model: Research Beam Product ID: 280917 5370 USD New
World Interventional Cardiology & Peripheral Vascular Devices Market - Opportunities and Forecasts, 2014 - 2020

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

World Interventional Cardiology & Peripheral Vascular Devices Market - Opportunities and Forecasts, 2014 - 2020

 
 
 

Interventional cardiology & peripheral vascular devices market is driven by increasing count of aging population and rising demand for angioplasty procedures which are minimally invasive. Furthermore, technological enhancements in interventional cardiology & peripheral vascular devices is expected to boost the market growth. The application of preliminary conventional first-level medication and rising cases of product recall is expected to hinder the market growth. Demand of stents having bioabsorbable properties across emerging markets is anticipated to offer abundant growth opportunities. Irregularity in reimbursements along with entry barriers for new players are the key market challenges.

The market is segmented on the basis of types of devices, procedure and geography. On the basis of types, the market is segmented into angioplasty stents market and catheters market. On the basis of procedure, the market is segmented into endovascular aneurysm repair (EVAR), stent grafts market, inferior vena cava (IVC) filters market, plaque modification devices market, hemodynamic flow alteration devices market and accessories market. On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).

Key market players profiled in this report are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Cordis Corporation (A Subsidiary of Johnson & Johnson Co.), Medtronic, Inc., Spectranetics International BV, St. Jude Medical, Inc. and Terumo Corporation.

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides a comprehensive analysis of current & future market trends, key market challenges and emerging avenues for the growth of this market globally.
  • The report offers latest technological innovations and the recent R&D developments.
  • The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.
  • This report entails the detailed quantitative analysis of the current market and estimations through 2014 and 2020, which assists in identifying the prevailing opportunities.
  • The report offers detailed segmentation and analyzes the key segments in terms of market size by value and volume and country-level analysis to provide an in-depth understanding.
  • Porters Five Forces analysis is offered in the report along with highlighting bargaining power of buyers and suppliers.
  • The report offers strategic analysis of financial status of key players, and highlights market share of main vendors.
  • The report offers information on the status of new projects along with offering investment feasibility analysis of the same.

KEY MARKET SEGMENTS:

  • By Type
    • Angioplasty Stents Market
    • Catheters Market
  • By Device
    • Endovascular Aneurysm Repair (EVAR)
    • Stent Grafts Market
    • inferior vena cava (IVC) Filters Market
    • Plaque Modification Devices Market
    • Hemodynamic Flow Alteration Devices Market
    • Accessories Market
  • By Geography
    • North America
    • Europe
    • Asia-Pacific
    • LAMEA

Key Company Profile

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • C.R. Bard
  • Cordis Corporation (A Subsidiary of Johnson & Johnson Co.)
  • Medtronic, Inc.
  • Spectranetics International BV
  • St. Jude Medical, Inc.
  • Terumo Corporation.

CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Key players
1.5 Research methodology

1.5.1 Secondary research
1.5.2 Primary research
1.5.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.2.2.1 Competitive intelligence of companies and their strategies

3.3 Market share analysis, 2015
3.4 Market dynamics

3.4.1 Drivers

3.4.1.1 Growing geriatric population and increasing prevalence of chronic diseases
3.4.1.2 Technological advancements
3.4.1.3 Improving healthcare infrastructure in developing countries
3.4.1.4 Development of minimally invasive procedures
3.4.1.5 Increasing patient awareness

3.4.2 Restraints

3.4.2.1 High treatment cost
3.4.2.2 Stringent approval process for interventional cardiology and peripheral vascular devices

3.4.3 Opportunities

3.4.3.1 Huge market opportunities in developing countries
3.4.3.2 Development of Bioabsorbable stents

3.5 Clinical Trials

CHAPTER 4 WORLD INTERVENTIONAL CARDIOLGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast

4.2 Angioplasty Balloons

4.2.1 Old/Normal balloons
4.2.2 Cutting and scoring balloons
4.2.3 Drug eluting balloons
4.2.4 Key market trends
4.2.5 Key growth factors and opportunities
4.2.6 Market size and forecast

4.3 Angioplasty Stents

4.3.1 Coronary stents

4.3.1.1 Bare-metal stents
4.3.1.2 Drug-eluting stents (DES)
4.3.1.3 Bioabsorbable stents

4.3.2 Peripheral stents
4.3.3 Key market trends
4.3.4 Key growth factors and opportunities
4.3.5 Market size and forecast

4.4 Angioplasty Catheters

4.4.1 Angiography Catheters
4.4.2 Guiding Catheters
4.4.3 Key market trends
4.4.4 Key growth factors and opportunities
4.4.5 Market size and forecast

4.5 Endovascular Aneurysm Repair Stent Grafts

4.5.1 Abdominal aortic aneurysm
4.5.2 Thoracic aortic aneurysm
4.5.3 Key market trends
4.5.4 Key growth factors and opportunities
4.5.5 Market size and forecast

4.6 Inferior Vena Cava (IVC) Filters

4.6.1 Permanent filters
4.6.2 Retrievable filters
4.6.3 Key market trends
4.6.4 Key growth factors and opportunities
4.6.5 Market size and forecast

4.7 Plaque Modification Devices

4.7.1 Thrombectomy devices
4.7.2 Atherectomy devices
4.7.3 Key market trends
4.7.4 Key growth factors and opportunities
4.7.5 Market size and forecast

4.8 Hemodynamic Flow Alteration Devices

4.8.1 Embolic protection devices
4.8.2 Chronic total occlusion devices
4.8.3 Key market trends
4.8.4 Key growth factors and opportunities
4.8.5 Market size and forecast

4.9 Accessories

4.9.1 Vascular closure devices
4.9.2 Introducer sheaths
4.9.3 Guidewires
4.9.4 Balloon inflation devices
4.9.5 Key market trends
4.9.6 Key growth factors and opportunities
4.9.7 Market size and forecast

CHAPTER 5 WORLD INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2014-2022

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 U.S. market size and forecast
5.2.5 Canada market size and forecast
5.2.6 Mexico market size and forecast

5.3 Europe

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.3.4 Germany market size and forecast
5.3.5 France market size and forecast
5.3.6 U.K. market size and forecast
5.3.7 Italy market size and forecast
5.3.8 Spain market size and forecast
5.3.9 Rest of Europe market size and forecast

5.4 Asia-Pacific

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Japan market size and forecast
5.4.5 China market size and forecast
5.4.6 India market size and forecast
5.4.7 Malaysia market size and forecast
5.4.8 Australia market size and forecast
5.4.9 Rest of Asia-Pacific market size and forecast

5.5 LAMEA

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.5.4 Brazil market size and forecast
5.5.5 South Africa market size and forecast
5.5.6 Egypt market size and forecast
5.5.7 Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Abbott Laboratories

6.1.1 Company Overview
6.1.2 Company Snapshot
6.1.3 Operating Business Segments
6.1.4 Business Performance
6.1.5 Key Strategic Moves & Developments

6.2 B. Braun Melsungen AG

6.2.1 Company Overview
6.2.2 Company Snapshot
6.2.3 Operating Business Segments
6.2.4 Business Performance
6.2.5 Key Strategic Moves & Developments

6.3 Boston Scientific Corporation

6.3.1 Company Overview
6.3.2 Company Snapshot
6.3.3 Operating Business Segments
6.3.4 Business Performance
6.3.5 Key Strategic Moves & Developments

6.4 C. R. Bard, Inc.

6.4.1 Company Overview
6.4.2 Company Snapshot
6.4.3 Operating Business Segments
6.4.4 Business Performance
6.4.5 Key Strategic Moves & Developments

6.5 Cardinal Health, Inc.

6.5.1 Company Overview
6.5.2 Company Snapshot
6.5.3 Operating Business Segments
6.5.4 Business Performance
6.5.5 Key Strategic Moves & Developments

6.6 Cook Medical, Inc.

6.6.1 Company Overview
6.6.2 Company Snapshot
6.6.3 Operating Business Segments
6.6.4 Key Strategic Moves & Developments

6.7 Medtronic plc

6.7.1 Company Overview
6.7.2 Company Snapshot
6.7.3 Operating Business Segments
6.7.4 Business Performance
6.7.5 Key Strategic Moves & Developments

6.8 St. Jude Medical, Inc.

6.8.1 Company Overview
6.8.2 Company Snapshot
6.8.3 Operating Business Segments
6.8.4 Business Performance
6.8.5 Key Strategic Moves & Developments

6.9 Terumo Corporation

6.9.1 Company Overview
6.9.2 Company Snapshot
6.9.3 Operating Business Segments
6.9.4 Business Performance
6.9.5 Key Strategic Moves & Developments

6.10 The Spectranetics Corporation

6.10.1 Company Overview
6.10.2 Company Snapshot
6.10.3 Operating Business Segments
6.10.4 Business Performance
6.10.5 Key Strategic Moves & Developments

List of Charts

FIG. 1 WORLD INTERVENTIONAL CRDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2015 VS 2022, ($MILLION)
FIG. 2 INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION
FIG. 3 TOP INVESTMENT POCKETS
FIG. 4 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIG. 5 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 6 TOP COMPANIES AND THEIR STRATEGIES
FIG. 7 DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIG. 8 DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIG. 9 MARKET SHARE ANALYSIS, 2015
FIG. 10 TOP IMPACTING FACTORS: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET
FIG. 11 CLINICAL TRIALS IN WORLD INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET
FIG. 12 CLINICAL TRIALS FOR INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES, (%)
FIG. 13 WORLD PERIPHERAL STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIG. 14 U.S. INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 15 CANADA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 16 MEXICO INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 17 GERMANY INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 18 FRANCE INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 19 U.K. INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 20 ITALY INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 21 SPAIN INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 22 REST OF EUROPE INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 23 JAPAN INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 24 CHINA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 25 INDIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 26 MALAYSIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 27 AUSTRALIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 28 REST OF ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 29 BRAZIL INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 30 SOUTH AFRICA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 31 EGYPT INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 32 REST OF LAMEA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 33 ABBOTT: NET SALES, 2013-2015 ($MILLION)
FIG. 34 ABBOTT: NET SALES, BY SEGMENT, 2015 (%)
FIG. 35 ABBOTT: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 36 ABBOTT: STRATEGY SHARE, (%)
FIG. 37 B. BRAUN: NET SALES, 2013-2015 ($MILLION)
FIG. 38 B. BRAUN: NET SALES, BY SEGMENT, 2015 (%)
FIG. 39 B. BRAUN: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 40 BOSTON SCIENTIFIC: NET SALES, 2013-2015 ($MILLION)
FIG. 41 BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2015 (%)
FIG. 42 BOSTON SCIENTIFIC: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 43 BOSTON SCIENTIFIC: STRATEGY SHARE, (%)
FIG. 44 BARD: NET SALES, 2013-2015 ($MILLION)
FIG. 45 BARD: NET SALES, BY SEGMENT, 2015 (%)
FIG. 46 BARD: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 47 CARDINAL HEALTH: NET SALES, 2014-2016 ($MILLION)
FIG. 48 CARDINAL HEALTH: NET SALES, BY SEGMENT, 2016 (%)
FIG. 49 CARDINAL HEALTH: NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 50 MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIG. 51 MEDTRONIC: NET SALES, BY SEGMENT, 2016 (%)
FIG. 52 MEDTRONIC: NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 53 MEDTRONIC: STRATEGY SHARE, (%)
FIG. 54 ST. JUDE MEDICAL: NET SALES, 2013-2015 ($MILLION)
FIG. 55 ST. JUDE MEDICAL: NET SALES, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 56 ST. JUDE MEDICAL: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 57 ST. JUDE MEDICAL: STRATEGY SHARE, (%)
FIG. 58 TERUMO: NET SALES, 2014-2016 ($MILLION)
FIG. 59 TERUMO: NET SALES, BY SEGMENT, 2016 (%)
FIG. 60 TERUMO: NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 61 TERUMO: STRATEGY SHARE, (%)
FIG. 62 SPECTRANETICS: NET SALES, 2013-2015 ($MILLION)
FIG. 63 SPECTRANETICS: NET SALES, BY SEGMENT, 2015 (%)
FIG. 64 SPECTRANETICS: NET SALES, BY PRODUCT LINE, 2015 (%)
FIG. 65 SPECTRANETICS: STRATEGY SHARE, (%)

List of Tables

TABLE 1 WORLD INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 2 WORLD ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 3 ANGIOPLASTY BALLOONS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 4 WORLD ANGIOPLASTY STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 5 WORLD CORONARY STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 6 ANGIOPLASTY STENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 7 WORLD ANGIOPLASTY CATHETERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 8 ANGIOPLASTY CATHETERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 9 WORLD ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 10 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11 TYPES OF IVC FILTERS AVAILABLE IN THE MARKET
TABLE 12 WORLD INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 13 INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14 WORLD PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 15 PLAQUE MODIFICATION DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16 WORLD HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 17 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 18 WORLD ACCESSORIES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 19 ACCESSORIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20 INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 22 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 23 EUROPE: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 24 EUROPE: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 25 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 26 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 27 LAMEA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 28 LAMEA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 29 ABBOTT: COMPANY SNAPSHOT
TABLE 30 ABBOTT: OPERATING SEGMENTS
TABLE 31 B. BRAUN: COMPANY SNAPSHOT
TABLE 32 B. BRAUN: OPERATING SEGMENTS
TABLE 33 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 34 BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 35 BARD: COMPANY SNAPSHOT
TABLE 36 BARD: OPERATING SEGMENTS
TABLE 37 CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 38 CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 39 COOK MEDICAL: COMPANY SNAPSHOT
TABLE 40 COOK MEDICAL: DIVISIONS
TABLE 41 MEDTRONIC: COMPANY SNAPSHOT
TABLE 42 MEDTRONIC: OPERATING SEGMENTS
TABLE 43 ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 44 ST. JUDE MEDICAL: PRODUCT CATEGORIES
TABLE 45 TERUMO: COMPANY SNAPSHOT
TABLE 46 TERUMO: OPERATING SEGMENTS
TABLE 47 SPECTRANETICS: COMPANY SNAPSHOT
TABLE 48 SPECTRANETICS: OPERATING SEGMENTS